Yang, S., Li, W., Bai, X., Nunzio, G. D., Fan, L., Zhao, Y., . . . Wang, J. (2024). Ginseng-derived nanoparticles alleviate inflammatory bowel disease via the TLR4/MAPK and p62/Nrf2/Keap1 pathways. BMC.
Cita Chicago (17th ed.)Yang, Song, et al. Ginseng-derived Nanoparticles Alleviate Inflammatory Bowel Disease via the TLR4/MAPK and P62/Nrf2/Keap1 Pathways. BMC, 2024.
Cita MLA (9th ed.)Yang, Song, et al. Ginseng-derived Nanoparticles Alleviate Inflammatory Bowel Disease via the TLR4/MAPK and P62/Nrf2/Keap1 Pathways. BMC, 2024.
Atenció: Aquestes cites poden no estar 100% correctes.